FRAX Based Guidelines: Is a Universal Model Appropriate?

Similar documents
FRAX Based Lebanese Osteoporosis Guidelines Second Update for Lebanese Guidelines for Osteoporosis Assessment and Treatment

FRAX Based Lebanese Osteoporosis Guidelines Second Update for Lebanese Guidelines for Osteoporosis Assessment and Treatment

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Executive Summary- Lebanese FRAX-Based Osteoporosis Guidelines 2013

Disclosures Fractures:

FIRST UPDATE OF THE LEBANESE GUIDELINES FOR OSTEOPOROSIS ASSESSMENT AND TREATMENT

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009

THE 8 TH ANNUAL MEETING OF THE LEBANESE SOCIETY FOR THE OSTEOPOROSIS & METABOLIC BONE DISORDERS

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

Global EHS Resource Center

Using the FRAX Tool. Osteoporosis Definition

OSTEOPOROSIS ESSENTIALS: DENSITOMETRY, DIAGNOSIS & MANAGEMENT

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

NICE SCOOP OF THE DAY FRAX with NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

Ghada El-Hajj Fuleihan, MD,MPH.

FRAX Identifying people at high risk of fracture

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

International Journal of Health Sciences and Research ISSN:

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

OSTEOPOROSIS ESSENTIALS: DENSITOMETRY, DIAGNOSIS & MANAGEMENT

OSTEOPOROSIS ESSENTIALS: DENSITOMETRY, DIAGNOSIS & MANAGEMENT

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Australian Journal of Basic and Applied Sciences

Clinical Practice. Presented by: Internist, Endocrinologist

Terms and Conditions. VISA Global Customer Assistance Services

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014

Choice of osteoporosis guideline has important implications for the treatment decision in elderly women referred to a fall clinic

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

World Connections Committee (WCC) Report

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

The application of FRAX to determine inter vention thresholds in osteoporosis treatment in Poland

Field of Post-M.D. Training

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Main developments in past 24 hours

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

The 7 th Annual Meeting of the Lebanese Society for OSTEOPOROSIS & METABOLIC BONE DISORDERS

WCPT COUNTRY PROFILE December 2017 SERBIA

EASY-Care program in Iran. Dr Reza Fadayevatan, MD, MPH, PhD Head of Ageing Department, The University of Social welfare and Rehabilitation Sciences

The Test-Curriculum Matching Analysis: Science

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

BioPlex 2200 Infectious Disease Panels

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Louisville '19 Attachment #69

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT

Appendix F: Test-Curriculum Matching Analysis

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

NGUYEN THI NGOC LAN- TAO THI MINH THUY

Summary of Results for Laypersons

Where we stand in EFORT

Appendix G How to start and expand Fracture Liaison Services

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Allied Health: Sustainable Integrated Health Care for all Australians

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

How to start and expand Fracture Liaison Services

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Osteoporosis Management in Older Adults

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

DINE AND LEARN ENDOCRINOLOGY PEARLS. Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC

Beyond the T-score: New Thinking in Osteoporosis 2

Management of postmenopausal osteoporosis

Preventing the next fracture

Prof. Renata Cífková, MD, CSc.

Osteoporosis Screening and Treatment in Type 2 Diabetes

- Network for Excellence in Health Innovation

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Immunohematology. IH-QC Modular System. Select. Combine. Control.

For personal use only

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Trabecular Bone Score (TBS)

Reza Fadayevatan Vida Alizad Ali Asgari

NobelDesign 1.3 Installation guide

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Monitoring Osteoporosis Therapy

Transcription:

FRAX Based Guidelines: Is a Universal Model Appropriate? Marlene Chakhtoura, MD Research Fellow Calcium Metabolism & Osteoporosis Program WHO Collaborating Center for Metabolic Bone Disorders American University of Beirut-Medical Center

FRAX Based Guidelines: Is a Universal Model Appropriate? - Marlene Chakhtoura, MD - Ghada El-Hajj Fuleihan, MD, MPH American University of Beirut Medical Center Beirut, Lebanon - Angela Cheung, MD, PhD, FRCP(C), CCD University Health Network, Toronto - Eugene McCloskey, MB, BCh, BAO, MD, FRCPI, FRCPE - John A Kanis, MD, FRCP University of Sheffield, United Kingdom - Michael McClung, MD, FACE, FACP Oregon Osteoporosis Center, Portland - William D. Leslie, MD, FRCPC MSc University of Manitoba, Canada

Nothing to declare Conflict of interest

Background FRAX, launched in February 2008, estimates the 10-year probability of a major osteoporotic fracture (hip, clinical spine, humerus or distal forearm) and hip fracture. based on 11 clinical risk factors, with bone mineral density at the femoral neck an optional input. FRAX has been calibrated for use in 52 countries worldwide, taking into account population-specific life expectancy and fracture incidence rates. http://www.shef.ac.uk/frax; version 3.8; March 19, 2014

FRAX Based Osteoporosis Guidelines To date, several countries have incorporated FRAX based risk assessment in their guidelines. 4 paradigm models have been developed* FRAX Based Intervention Threshold Models NOGG http://www.shef.ac.uk Age-specific threshold model Canada http://www.osteoporosis.ca NOF http://nof.org/ Lebanon http://www.aub.edu.lb Fixed threshold model Composite model Hybrid model *Some EU countries have adopted models based on NOGG or T-score cut-offs

Age Specific Threshold Model NOGG

Age Specific Threshold Model NOGG Patients with a prior fragility fracture should be considered for treatment. In others the 10 year probability of a major osteoporotic fracture (clinical spine, hip, forearm or humerus) should be determined using FRAX. The intervention threshold is defined as the 10-year probability of major osteoporotic fracture in a woman with a BMI of 25 kg/m² who has had a previous fracture (without additional risk factors). http://www.shef.ac.uk/nogg/

Age Specific Threshold Model NOGG Patients with a prior fragility fracture should be considered for treatment. In others the 10 year probability of a major osteoporotic fracture (clinical spine, hip, forearm or humerus) should be determined using FRAX. The intervention threshold is defined as the 10-year probability of major osteoporotic fracture in a woman with an identical age, a BMI of 25 kg/m² who has had a previous fracture (without additional risk factors). http://www.shef.ac.uk/nogg/

Fixed Model Canadian FRAX Based Guidelines Initial BMD Testing Assessment of fracture risk Low risk 10-year fracture risk < 10% Unlikely to benefit from pharmacotherapy Reassess in 5 yr Moderate risk 10-year fracture risk 10%-20% Lateral TL (T4-L4) or vertebral fracture assessment may aid in decision-making by identifying vertebral fractures Factors warranting consideration of pharmacologic therapy High risk 10-year fracture risk > 20% or prior fragility fracture of hip or spine or > 1 fragility fractures Always consider patient preference Good evidence of benefit from pharmacotherapy Papaioannou A, CMAJ 2010. 182: 17;1864-873

Composite Model NOF Treat post menopausal women and men > 50 years A hip or vertebral fracture BMD assessment FN or LS T-Score -2.5 Osteopenia if 10y risk for MOF 20% 10y risk for hip fracture 3%

Hybrid Model Lebanon Lebanese Guidelines 2002 & 2007 Definite Indications Postmenopausal women with fragility fracture Postmenopausal women T -2.5 (NHANES) Postmenopausal women on CS and T -1.5 Less Definite Indications T- score between -1 and -2.5 (with other risk factors) http://www.aub.edu.lb/fm/cmop/downloads/diagnosis-trt.pdf

Denmark Sweden Switzerland US Caucasian Austria UK Canada Taiwan Malta Japan Belgium S'pore Chinese S Korea S' Indian Argentina Hungary Hong Kong Italy Germany Finland Mexico Turkey Netherlands Romania France New Zealand Poland Jordan US Black Lebanon Spain Australia Colombia China Philippines Tunisia 10-year overall fracture risk Impact of T-score on Fracture Risk Prediction 20 18 16 14 12 10 8 6 4 2 0 Women age 65 years BMD T-score -2.5 BMI 25 kg/m² http://www.shef.ac.uk/frax; version 3.8; October 17, 2013

Denmark Sweden Switzerland US Caucasian Austria UK Canada Taiwan Malta Japan Belgium S'pore Chinese S Korea S' Indian Argentina Hungary Hong Kong Italy Germany Finland Mexico Turkey Netherlands Romania France New Zealand Poland Jordan US Black Lebanon Spain Australia Colombia China Philippines Tunisia 10-year overall fracture risk Impact of T-score on Fracture Risk Prediction 20 18 16 14 12 10 8 6 4 2 0 Women age 65 years BMD T-score -2.5 BMI 25 kg/m² http://www.shef.ac.uk/frax; version 3.8; October 17, 2013

10-year risk for major osteoporotic fracture NOGG Age Specific Threshold Model Applied to Lebanon 40 35 30 25 20 15 UK Lebanon 10 5 0 50 55 60 65 70 75 80 85 90 Age http://www.shef.ac.uk/frax; version 3.8; October 17, 2013

10-year risk for major osteoporotic fracture NOGG Age Specific Threshold Model Applied to Lebanon At ages <70 years, NOGG Lebanon sets intervention threshold for MOF 3-10%. 40 35 30 25 20 15 UK Lebanon 10 5 0 50 55 60 65 70 75 80 85 90 Age http://www.shef.ac.uk/frax; version 3.8; October 17, 2013

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women Women 50-55 55-60 60-65 65-70 70-75 75-80 80-85 85-

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women Women 50-55 26.3 55-60 28.5 60-65 30.4 65-70 33.0 70-75 30.0 75-80 30.5 80-85 28.2 85-24.6

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women Women 50-55 26.3 55-60 28.5 60-65 30.4 65-70 33.0 70-75 30.0 75-80 30.5 80-85 28.2 85-24.6

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women Women 50-55 26.3 0.00 55-60 28.5 0.04 60-65 30.4 0.44 65-70 33.0 2.8 70-75 30.0 9.8 75-80 30.5 22.5 80-85 28.2 35.8 85-24.6 42.7

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women Women 50-55 26.3 0.00 0.11 55-60 28.5 0.04 1.3 60-65 30.4 0.44 5.7 65-70 33.0 2.8 18.8 70-75 30.0 9.8 41.5 75-80 30.5 22.5 62.8 80-85 28.2 35.8 77.4 85-24.6 42.7 79.8

FRAX Based Osteoporosis Guidelines Proportion above intervention thresholds Age group NOGG Fixed 20% Fixed 10% Lebanon women women women 50-55 26.3 0.00 0.11 55-60 28.5 0.04 1.3 60-65 30.4 0.44 5.7 65-70 33.0 2.8 18.8 70-75 30.0 9.8 41.5 75-80 30.5 22.5 62.8 80-85 28.2 35.8 77.4 85-24.6 42.7 79.8

Women age (years) Hybrid Model: Lebanon Intervention threshold (%) Proportions above threshold* (%) for major osteoporotic fracture Fixed at 10% 50-55 10 0.11 55-60 10 1.3 60-65 10 5.7 65-70 10 18.8 NOGG Model 70-75 10-15 30 75-80 15-21 30 80-85 21-27 28 85-90 27-30 25 * Proportions include patients with fractures

Lebanese FRAX Based Guidelines 2013 Hybrid Model Definite Indications: regardless of FRAX and BMD Postmenopausal women and men 50 years with fragility fracture (Spine and Hip, More than one other fragility fractures) Postmenopausal women T -2.5 (NHANES) Postmenopausal women on CS and T 1.5 Less Definite Indications T- score between -1 and -2.5 (with/without risk factors) http://www.aub.edu.lb/fm/cmop/downloads/diagnosis-trt.pdf

Lebanese FRAX Based Guidelines 2013 Hybrid Model Definite indications: regardless of FRAX and BMD Postmenopausal women and men 50 years with fragility fracture (Spine and Hip, More than one other fragility fractures) http://www.aub.edu.lb/fm/cmop/downloads/diagnosis-trt.pdf

Case Scenario: FRAX Based Guidelines: Is a Universal Model Appropriate? A 75 years old lady presents for evaluation. Smoker FN T-score of -2.5 BMI 25kg/m² Country UK US Canada Lebanon 10y risk for MOF (%) 10y risk of hip fracture (%) Decision

Case Scenario: FRAX Based Guidelines: Is a Universal Model Appropriate? A 75 years old lady presents for evaluation. Smoker FN T-score of -2.5 BMI 25kg/m² Country UK US Canada Lebanon 10y risk for MOF (%) 17 19 18 13 10y risk of hip fracture (%) 7.9 8.9 7.9 6.6 Decision Do NOT treat TREAT Consider treatment Do NOT treat

Is a Universal Model Appropriate: Summary NOGG Model Reflects a translational approach to an intuitively attractive concept. The resulting cutoffs vary considerably between countries. They are low in countries with low fracture rates at younger ages: <10% They are high in countries with high fracture rates at older ages: 30-45% The model would imply intervening in a large proportion of young postmenopausal women, in countries with low/moderate fracture rates, such as Lebanon. NOF Model Easy to implement, age independent fixed threshold, MOF 20%, hip 3%. Results in treating a large proportion of elderly women in countries with low/ moderate fracture rates Lebanon (42% in women 85 years) New Zealand (46% in women with mean age 74 years) Bolland et al,2010 China (63% of women 65 years) Cheung et al,2013 Cost effective in US, but not necessarily in other countries. Canadian Model Grades risk into three categories allowing flexibility in decision making in the intermediate 10-20% overall MOF range

Conclusion The 4 models presented provide a platform to derive FRAX based guidelines to be tailored according to the profile and needs of each country. They provide a framework that does not supersede clinical judgment, including patient profiling and preference. No single model can address the individual limitations of each. Not all models implemented a cost utility approach. A universal model may not be appropriate since fracture risk, mortality, health priorities and resources vary between countries.

Acknowledgments Grant support from the Medical Resource Plan at the American University of Beirut and the Lebanese National Council for Scientific Research. Members of the Lebanese National Task Force for Osteoporosis: G El Hajj Fuleihan, A Arabi, N Atallah, R Baddoura, G Halaby, M Hout, J Okais, I Salti, M Seoud, A Rady, A Taha, and I Uthman. Lebanese scientific societies that endorsed the Lebanese FRAX based Osteoporosis Guidelines 2013: Lebanese Society for Osteoporosis and Metabolic Bone Disorders, OSTEOS; Lebanese Society of Endocrinology; Lebanese Society of Obstetrics and Gynecology; Lebanese Association of Orthopedic Surgeons; Lebanese Society of Radiology; Lebanese Society of Rheumatology; Lebanese Society of Family Medicine; Lebanese Society of Internal Medicine; Lebanese Society of General Practitioners. Lebanese Ministry of Health: endorsing the guidelines by ministerial decree.